dorsaVi Limited (AU:DVL)
ASX:DVL
Want to see AU:DVL full AI Analyst Report?
DVL Stock Chart & Stats
AU$0.03
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.03
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.07
Previous CloseN/A
Volume925.00K
Average Volume (3M)8.34M
Market Cap
AU$45.98M
Enterprise ValueAU$49.64M
Total Cash (Recent Filing)AU$4.95M
Total Debt (Recent Filing)AU$135.68K
Price to Earnings (P/E)―
Beta1.99
Next Earnings
Aug 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,210,028,400
10 Day Avg. Volume5,304,106
30 Day Avg. Volume8,343,384
Financial Highlights & Ratios
PEG Ratio1.57
Price to Book (P/B)3.65
Price to Sales (P/S)9.17
P/FCF Ratio-10.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Conservative Balance SheetA very low debt-to-equity ratio (0.055) gives the company durable financial flexibility: lower fixed financing costs, reduced bankruptcy risk, and more capacity to fund product development or absorb losses over months without forced deleveraging, supporting operational continuity.
Specialized Digital Health Wearable PlatformA focused product set in wearable biomechanics and clinical movement assessment is a structural advantage: specialized sensors and software create niche expertise, making it harder for generalist entrants to replicate clinical workflows and enabling durable B2B relationships with healthcare and enterprise customers.
Improving Free Cash Flow TrendAn improving free cash flow trend, even from negative levels, indicates operations are moving toward better cash conversion. If sustained, this reduces financing needs and strengthens runway, supporting longer-term investment in product adoption and sales channels over the next several months.
Bears Say
Declining Revenue TrendA sustained revenue decline reduces operating leverage and weakens the business model's scalability. If top-line contraction continues, it erodes margins, limits reinvestment in product and sales, and prolongs the path to profitable scale across clinical and enterprise channels.
Persistent Unprofitability / Negative MarginsConsistent negative net, EBIT and EBITDA margins indicate structural inability to cover operating costs at current scale. Persistent losses strain equity returns, restrict strategic options, and mean any growth will need to overcome entrenched margin shortfalls to reach sustainable profitability.
Negative Operating Cash Flow And Ongoing Cash BurnNegative operating cash flow signals the business currently consumes cash to run daily operations, requiring external funding or equity dilution to maintain growth. Over months, persistent cash burn raises financing risk and can constrain marketing, R&D and sales investments critical for adoption.
dorsaVi Limited News
DVL FAQ
What was dorsaVi Limited’s price range in the past 12 months?
dorsaVi Limited lowest share price was AU$0.01 and its highest was AU$0.07 in the past 12 months.
What is dorsaVi Limited’s market cap?
dorsaVi Limited’s market cap is AU$45.98M.
When is dorsaVi Limited’s upcoming earnings report date?
dorsaVi Limited’s upcoming earnings report date is Aug 21, 2026 which is in 70 days.
How were dorsaVi Limited’s earnings last quarter?
dorsaVi Limited released its earnings results on Feb 26, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is dorsaVi Limited overvalued?
According to Wall Street analysts dorsaVi Limited’s price is currently Overvalued.
Does dorsaVi Limited pay dividends?
dorsaVi Limited does not currently pay dividends.
What is dorsaVi Limited’s EPS estimate?
dorsaVi Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does dorsaVi Limited have?
dorsaVi Limited has 1,210,028,400 shares outstanding.
What happened to dorsaVi Limited’s price movement after its last earnings report?
dorsaVi Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of dorsaVi Limited?
Currently, no hedge funds are holding shares in AU:DVL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
dorsaVi Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:DVL Sentiment 90%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
―
20 days / 200 days
Momentum
363.63%
12-Months-Change
Fundamentals
Return on Equity
-102.57%
Trailing 12-Months
Asset Growth
210.78%
Trailing 12-Months
Company Description
dorsaVi Limited
dorsaVi Ltd, an Australian company established in 2008 and based in Oakleigh South, focuses on creating and distributing advanced motion analysis technologies throughout Australia, Europe, and the United States. Its product portfolio includes ViMove+, offering comprehensive solutions for both clinical and athletic applications. For workplace safety, dorsaVi provides ViSafe, a wearable sensor system engineered to track, analyze, and report on workforce movements, highlighting and pinpointing unsafe practices that contribute to occupational injuries. This is complemented by myViSafe technology, which enables organizations and on-site clinicians to identify, reduce, and prevent injury risks in the workplace, fostering positive behavioral changes. Additionally, the company offers ViPerform, a wearable and wireless movement sensor technology that supplies objective data for assessing the likelihood of sports injuries and guiding effective athletic training and recovery programs. dorsaVi also delivers telehealth solutions and professional suites to its clients.
Technical Analysis
X2M Connect Limited
―
―
Hydrix Limited
―
Beam Communications Holdings Limited
―
ZIMI Ltd
―
Options Prices
Currently, No data available
---